IBANDRONATE SODIUM
- Product NDC
- 62756-218
- 11-digit product format
- 627560218
- Labeler code
- 62756
- Product ID
- 62756-218_61378ee8-cc2f-4f55-954b-4eb55e975f5c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- IBANDRONATE SODIUM
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA090853
- Marketing category
- ANDA
- Marketing start
- 2014-02-15
- Substance
- IBANDRONATE SODIUM
- Active strength
- 3 mg/3mL
- Pharmacologic classes
- Bisphosphonate [EPC], Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- IBANDRONATE SODIUM
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IBANDRONATE SODIUM | 3 mg/3mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | J12U072QL0 |
| Rxcui | 904955 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6bd95106-a412-1dad-b9cc-4cb74bfb27ce | Product name | 2 | 20230315 |
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| fca0fe5b-9e2b-f6fc-e68d-b5f751d08578 | Product name | 3 | 20180103 |
| a7e2afc7-9184-42ab-b6c6-6edca00dd2d2 | Product name | 4 | 20160310 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 290f523a-f9db-9774-b5a9-e1f908ac1782 | Product name | 1 | 20150828 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| c6b65c52-69c7-df49-550a-a50c137f6218 | Product name | 1 | 20140508 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62756-218-40 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-64a2-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use IBANDRONATE SODIUM INJECTION safely and effectively. See full prescribing information for IBANDRONATE SODIUM INJECTION. IBANDRONATE SODIUM injection, for intravenous use Initial U.S. Approval: 2003 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62756-218-40 | IBANDRONATE SODIUM | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 6 | |
| 62756-218-40 | IBANDRONATE SODIUM | 3 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 3 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62756-218-40 | ML - Milliliter | 62756-218 | 565fb9b7-bd67-4701-add4-fc4a163300bd | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| IBANDRONATE SODIUM | ACTIVE INGREDIENT | J12U072QL0 | IBANDRONATE SODIUM INJECTION, SOLUTION [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 | |
| IBANDRONIC ACID | ACTIVE MOIETY | UMD7G2653W | IBANDRONATE SODIUM INJECTION, SOLUTION [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | IBANDRONATE SODIUM INJECTION, SOLUTION [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 | |
| SODIUM ACETATE | INACTIVE INGREDIENT | 4550K0SC9B | IBANDRONATE SODIUM INJECTION, SOLUTION [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | IBANDRONATE SODIUM INJECTION, SOLUTION [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | IBANDRONATE SODIUM INJECTION, SOLUTION [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 904955 | ibandronate sodium 3 MG in 3 ML Injection | PSN | be514be6-727a-4d6c-993b-52144f8e6de8 | 6 |
| 904955 | 3 ML ibandronic acid 1 MG/ML Injection | SCD | be514be6-727a-4d6c-993b-52144f8e6de8 | 6 |
| 904955 | ibandronic acid 1 MG/ML (as ibandronate sodium 1.13 MG/ML) Injection | SY | be514be6-727a-4d6c-993b-52144f8e6de8 | 6 |
| 904955 | ibandronic acid 3 MG per 3 ML (as ibandronate sodium 1.13 MG/ML) Injection | SY | be514be6-727a-4d6c-993b-52144f8e6de8 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 62756-218-40 | 62756021840 | 1 VIAL, SINGLE-DOSE in 1 CARTON (62756-218-40) / 3 mL in 1 VIAL, SINGLE-DOSE | 2014-02-15 | No | No | Current |